Laetrile: a survey of judicial and administrative activity.
The judicial and executive branches of the federal government, motivated by emotionalism, political pressure, and a self-appointed need to placate the National Cancer Institute, have reached a decision on laetrile that weakens the legal protection of the general public. Recent approval of clinical trials of laetrile by the Food and Drug Administration was not consistent with policies adopted earlier, nor was it warranted by federal court decisions.
D000678:Amygdalin; D002986:Clinical Trials as Topic; D007603:Jurisprudence; D007878:Legislation as Topic; D009316:National Institutes of Health (U.S.); D014481:United States; D014486:United States Food and Drug Administration
D000678:Amygdalin